Navigation Links
Amscot Financial Contributes to the Juvenile Diabetes Research Foundation, Supporting Upcoming 'Walk for a Cure'
Date:2/8/2008

KISSIMMEE, Fla., Feb. 8 /PRNewswire/ -- Amscot Financial, a leading provider of convenient, consumer-oriented financial services, invites all to come out and have fun "the Amscot way" at its open house on Saturday, February 9, from noon to 2 p.m. at 3260 Vineland Road in Kissimmee. Amscot will present a $500 contribution to the Central Florida chapter of the Juvenile Diabetes Research Foundation, which underwrites efforts to seek a cure for the disease.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060316/FLAMSCOTLOGO )

The Walk To Cure Diabetes is the fastest growing fund raising event in the history of the Juvenile Diabetes Research Foundation, (JDRF). In 2007, the national JDRF raised nearly $100 million with the Walk, which spans more than 200 chapters throughout the United States and six countries. The Central Florida chapter raised more than $815,000 in 2007 with its two premier walks in Central Florida. The first walk is scheduled for March 1 at the University of Central Florida; the second is scheduled for March 15 at Lori Wilson Park in Brevard County.

During the Amscot open house event, children's entertainment will be provided. Radio station WRUM-FM, Rumba 100.3, will broadcast live from Amscot's parking lot and give away prizes. Free refreshments also will be provided.

At the Amscot grand opening, the Child Protection Education of America, Inc. (CPEA), a national nonprofit organization for missing children based in Tampa, will also be available on site to provide free fingerprinting for children through their "ID ME NOW" program.

The program produces a state-of-the-art, specially designed card for parents to keep. The card contains a set of the child's digital fingerprints, a black and white photo, a dental chart, and instructions on how to do a simple DNA collection. Safety brochures are provided with the fingerprint card, as we
'/>"/>

SOURCE Amscot Financial
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Align Technology Executives to Present at Upcoming Financial Conferences
2. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
3. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
4. Oncology Metrics Launches the National Practice Benchmark: One in a Series of Initiatives to Help Community Oncology Practices Better Measure Operational and Financial Performance
5. HMS Holdings Corp. Hosts Fourth Quarter and Full Year 2007 Financial Teleconference and Presentation
6. Jazz Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2007 Financial Results on February 13, 2008
7. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
8. Genomic Health Announces Fourth Quarter and Year-End 2007 Financial Results and Business Progress and 2008 Financial Guidance
9. AtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2007 Financial Results
10. Darwin to Announce Fourth Quarter and Year-end 2007 Financial Results
11. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... 28, 2015 Could genetic code determine ... study by researchers at the Harvard T.H. ... the support of the Coffee and Caffeine Genetics Consortium ... this past fall, the study—one of several recent HSPH ... data from more than 120,000 regular coffee drinkers of ...
(Date:3/28/2015)... 28, 2015 Take a bite of ... into action. Acids tumble into the stomach, ready to ... valve-like structure lets these acids run amok, triggering a ... common symptom. More than 60 million Americans have heartburn ... where heartburn starts, and how it can be stopped. ...
(Date:3/28/2015)... 28, 2015 Thousands of transvaginal ... by C.R. Bard, Inc. continue to move forward ... Court, Southern District of West Virginia, where Bernstein ... the Plaintiffs’ Steering Committee. According to an ... certain defendants named in those lawsuits leave to ...
(Date:3/28/2015)... 28, 2015 Emergency Medical Care (EMC), ... in Manhattan, recently commemorated its three-year anniversary of being ... In addition to 24-hour urgent care, Emergency Medical Care ... At this time, Emergency Medical Care’s Urgent Care ... chest pain, eye injuries, ear infections, fevers, insect bites, ...
(Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
Breaking Medicine News(10 mins):Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 2Health News:How Coffee Habits Relate to Our Genetic Code and Enhancing the Caffeine Experience 3Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4
... News) -- Surgery can improve eye comfort and quality of ... their eyes, according to a small, new study. The ... for the cornea, which "can lead to exposure keratitis [inflammation ... wrote Dr. Douglas K. Henstrom, of Harvard Medical School and ...
... HealthDay Reporter , MONDAY, March 21 (HealthDay News) -- ... worst cases of potentially life-threatening blood clots that form in ... break loose and travel to the lungs, causing a pulmonary ... United States more than 250,000 people are hospitalized for deep ...
... HealthDay Reporter , MONDAY, March 21 (HealthDay News) ... gastric banding say they are generally satisfied years later, almost ... have to have their bands removed, a small, new Belgian ... a recent study out of the University of California, San ...
... new study published by researchers at Weill Cornell Medical ... in patient outcomes after a major earthquake through more ... hub to manage electronic traffic between first responders and ... injured victims will get timely care and survive, according ...
... March 21 (HealthDay News) -- People appear to be ... in a traffic crash than after other physically traumatic ... Gareth Jones, of the University of Aberdeen School of ... 2,069 people who provided information about musculoskeletal pain and ...
... patients in a federally funded study to determine if a ... "The question is, if you have kidney disease, should your ... of the GHSU Section of Nephrology and a principal investigator ... by the National Institutes of Health. The ...
Cached Medicine News:Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 2Health News:Severe Blood Clots Should be Treated Aggressively: Heart Docs 3Health News:40% of Gastric Banding Patients Have Complications 2Health News:40% of Gastric Banding Patients Have Complications 3Health News:40% of Gastric Banding Patients Have Complications 4Health News:Health information technology 'control tower' could improve earthquake response 2Health News:Chronic Pain Often Follows Car Crash: Study 2Health News:Study examines whether lower blood pressure reduces kidney disease progression 2
(Date:3/27/2015)... , March 27, 2015 XRpro ... for drug discovery and development services which features ... the pharmaceutical industry, announced financial results for the ... Timothy C.  Tyson, Chairman of XRpro Sciences commented, ... successfully transition from development stage to commercial stage ...
(Date:3/27/2015)... March 27, 2015 According to ... (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, ... Indication (AF, VT, WPW) - Global Forecasts to 2019 ", ... to reach around ~$4.73 Billion by 2019 with a ... to 2019. Browse   90   ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Calif., May 18, 2011 Bayer HealthCare Pharmaceuticals, ... ONXX ) today announced results from a Phase ... with locally advanced or metastatic breast cancer previously ... Nexavar was associated with statistically significant improvements in ...
... SEATTLE, May 18, 2011 Dendreon Corporation (Nasdaq: ... poster presentation detailing clinical trial plans for PROVENGE® (sipuleucel-T) and ... upcoming American Society for Clinical Oncology annual meeting in Chicago, ... on Monday, June 6, 2011, from 8:00 a.m. to 12:00 ...
Cached Medicine Technology:Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 2Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 3Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 4Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 5Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 6Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 7Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study 8Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 2Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 3Dendreon Announces Clinical Trial Plans for PROVENGE and DN24-02 at the American Society of Clinical Oncology Annual Meeting 4
For the quantitative determination of calcium in serum. Endpoint Reaction Product measured at 570 nm Linearity: 20 mg/dl...
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum....
... Intended for the quantitative determination ... serum or plasma. Two vials, ... tablets must be purchased separately ... Kinetic reaction. Wavelength: 340 nm. ...
... quantitative determination of alanine aminotransferase ... Single vial, dry powder reagent. ... purchased separately for conformity to ... 340 nm. Linearity: 440 U/L ...
Medicine Products: